🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary trial objective is to determine the efficacy of KPT-330 (seline...
Status
Completed
Location
UZ Leuven - Universitair Ziekenhuis Leuven
Start Date
2014-04-09
Trial ID
NCT02025985
Treatments Being Tested
This is a multi-center, phase 2, single arm, open-label study of oral selin...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2014-11-14
Trial ID
NCT02138786
Treatments Being Tested
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
The main purpose of this study is to determine the recommended doses of sel...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-09-23
Trial ID
NCT02186834
Treatments Being Tested
This clinical trial studies the efficacy and safety of selinexor combined w...
Status
Recruiting
Location
Tao Wang
Start Date
2023-01-29
Trial ID
NCT05726110
Double-blind study will compare the efficacy and assess safety of selinexor...
Status
Withdrawn
Location
James R. Berenson MD, Inc
Start Date
2015-12
Trial ID
NCT02628704
Treatments Being Tested
This is a phase 1b study of investigational drug selinexor in combination w...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2017-05-16
Trial ID
NCT03042819
Treatments Being Tested
Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Status
Recruiting
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2026-04-01
Trial ID
NCT07523737
Treatments Being Tested
The purpose of this study is to find out what effects new combinations of t...
Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Start Date
2015-10-27
Trial ID
NCT02436707
The purpose of this Phase 2/3 study is to evaluate efficacy and safety of t...
Status
Active Not Recruiting
Location
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers
Start Date
2020-09-03
Trial ID
NCT04442022
Treatments Being Tested